IBM, UCB in big data deal for epilepsy

IBM Corp. (NYSE:IBM) and UCB Group (Euronext:UCB) partnered to develop a point-of-care analytics system to predict the probability of success of epilepsy treatments to inform treatment decisions. The partners said they completed proof of concept (POC) of a system in which they used data from anonymous patient records from IMS Health for 1.5 million U.S. epilepsy patients along with an "analytics machine approach" to model and predict outcomes of epilepsy treatments. UCB said the partners plan to publish the POC data and look for external stakeholders for collaborations to develop a point-of-care system, but declined to disclose details. The company declined to disclose details on who would own rights to any resulting system. ...